Risk-reducing mastectomy in ovarian cancer patients with BRCA1/2 pathogenic variants: a comprehensive review

被引：0
|
作者：
Bonci, E. -A. [1 ,2 ,3 ]
O'Connell, R. [4 ,5 ]
McVeigh, T. [6 ]
Kemp, Z. [7 ]
George, A. [4 ,5 ,8 ]
Cardoso, M. -J. [3 ,9 ]
Banerjee, S. [8 ]
Gui, G. [4 ]
Tasoulis, M. -K. [4 ,5 ]
机构：
[1] Iuliu Hatieganu Univ Med & Pharm, Surg Oncol & Gynecol Oncol Dept, Cluj Napoca, Romania
[2] Prof Dr Ion Chiricuta Inst Oncol, Dept Surg Oncol, Cluj Napoca, Romania
[3] Champalimaud Fdn, Breast Canc Unit, Champalimaud Clin Ctr, Lisbon, Portugal
[4] Royal Marsden NHS Fdn Trust, Breast Surg Unit, London, England
[5] Inst Canc Res, London, England
[6] Royal Marsden NHS Fdn Trust, Canc Genet, London, England
[7] Royal Marsden NHS Fdn Trust, Breast Med Oncol Unit, London, England
[8] Royal Marsden NHS Fdn Trust, Gynaecol Med Oncol Unit, London, England
[9] Fac Med, Lisbon, Portugal
来源：
BREAST | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P064
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis
    Metcalfe, Kelly
    Huzarski, Tomasz
    Gronwald, Jacek
    Kotsopoulos, Joanne
    Kim, Raymond
    Moller, Pal
    Pal, Tuya
    Aeilts, Amber
    Eisen, Andrea
    Karlan, Beth
    Bordeleau, Louise
    Tung, Nadine
    Olopade, Olufunmilayo
    Zakalik, Dana
    Singer, Christian F.
    Foulkes, William
    Couch, Fergus
    Neuhausen, Susan L.
    Eng, Charis
    Sun, Ping
    Lubinski, Jan
    Narod, Steven A.
    BRITISH JOURNAL OF CANCER, 2023, 130 (2) : 269 - 274
  • [2] Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis
    Kelly Metcalfe
    Tomasz Huzarski
    Jacek Gronwald
    Joanne Kotsopoulos
    Raymond Kim
    Pal Moller
    Tuya Pal
    Amber Aeilts
    Andrea Eisen
    Beth Karlan
    Louise Bordeleau
    Nadine Tung
    Olufunmilayo Olopade
    Dana Zakalik
    Christian F. Singer
    William Foulkes
    Fergus Couch
    Susan L. Neuhausen
    Charis Eng
    Ping Sun
    Jan Lubinski
    Steven A. Narod
    British Journal of Cancer, 2024, 130 : 269 - 274
  • [3] Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants
    Choi, Yun-Hee
    Terry, Mary Beth
    Daly, Mary B.
    MacInnis, Robert J.
    Hopper, John L.
    Colonna, Sarah
    Buys, Saundra S.
    Andrulis, Irene L.
    John, Esther M.
    Kurian, Allison W.
    Briollais, Laurent
    JAMA ONCOLOGY, 2021, 7 (04) : 585 - 592
  • [4] Bilateral risk-reducing mastectomy is the safest strategy in BRCA1
    Pilgrim, S.
    Pain, S.
    EJSO, 2014, 40 (06): : 670 - 672
  • [5] Management of ovarian cancer risk in women with BRCA1/2 pathogenic variants
    Walker, Melissa
    Jacobson, Michelle
    Sobel, Mara
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (32) : E886 - E893
  • [6] Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers A Complex Discussion
    Domchek, Susan M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (01): : 27 - 28
  • [7] Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation
    Jung, Sung Mi
    Ryu, Jai Min
    Park, Hyung Seok
    Park, Ji Soo
    Kang, Eunyoung
    Lee, Seeyoun
    Lee, Han-Byoel
    Youn, Hyun Jo
    Yoo, Tae-Kyung
    Kim, Jisun
    Lee, Jeong Eon
    Han, Sang Ah
    Kim, Dongwon
    Kim, Sung-Won
    JOURNAL OF BREAST CANCER, 2020, 23 (06) : 647 - 655
  • [8] Ovarian cancer risk of Chinese women with BRCA1/2 germline pathogenic variants
    Yao, Lu
    Sun, Jie
    Hu, Li
    Chen, Jiuan
    Zhang, Juan
    Xu, Ye
    Xie, Yuntao
    JOURNAL OF HUMAN GENETICS, 2022, 67 (11) : 639 - 642
  • [9] Ovarian cancer risk of Chinese women with BRCA1/2 germline pathogenic variants
    Lu Yao
    Jie Sun
    Li Hu
    Jiuan Chen
    Juan Zhang
    Ye Xu
    Yuntao Xie
    Journal of Human Genetics, 2022, 67 : 639 - 642
  • [10] Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center
    Assad, Hadeel
    Levitin, Maria
    Petrucelli, Nancie
    Manning, Mark
    Thompson, Hayley S.
    Chen, Wei
    Jang, Hyejeong
    Simon, Michael S.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (02) : 261 - 272
12345